Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene L Piatnitski Chekler

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Nature Chemical Biology|March 20, 2013
Target validation using chemical probesMark E Bunnage, Eugene L Piatnitski Chekler, Lyn H Jones
Journal of the American Chemical Society|November 3, 2010
Electrostatic docking of a supramolecular host-guest assembly to cytochrome c probed by bidirectional photoinduced electron transferKatarzyna I Jankowska, Cynthia V Pagba, Eugene L Piatnitski Chekler, et al.
Scientific Reports|December 17, 2015
Perturbation of cellular proteostasis networks identifies pathways that modulate precursor and intermediate but not mature levels of frataxinJoseph F Nabhan, Renea L Gooch, Eugene L Piatnitski Chekler, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Dual VEGFR-2 and Tubulin Inhibitors with in Vivo EfficacyEugene L Piatnitski Chekler, Alexander S Kiselyov, Xiaohu Ouyang, et al.
Bioorganic & Medicinal Chemistry Letters|July 22, 2008
Synthesis and evaluation of heteroaryl-ketone derivatives as a novel class of VEGFR-2 inhibitorsEugene L Piatnitski Chekler, Reeti Katoch-Rouse, Alexander S Kiselyov, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2009
Discovery of a class of potent gap-junction modifiers as novel antiarrhythmic agentsEugene L Piatnitski Chekler, John A Butera, Li Di, et al.
Journal of Medicinal Chemistry|April 5, 2017
Structure-Based Design of Highly Selective Inhibitors of the CREB Binding Protein BromodomainR Aldrin Denny, Andrew C Flick, Jotham Coe, et al.
Chemistry & Biology|December 17, 2015
Transcriptional Profiling of a Selective CREB Binding Protein Bromodomain Inhibitor Highlights Therapeutic OpportunitiesEugene L Piatnitski Chekler, Jessica A Pellegrino, Thomas A Lanz, et al.
Journal of Medicinal Chemistry|July 12, 2017
Structure-Based Approach To Identify 5-[4-Hydroxyphenyl]pyrrole-2-carbonitrile Derivatives as Potent and Tissue Selective Androgen Receptor ModulatorsRay Unwalla, James J Mousseau, Olugbeminiyi O Fadeyi, et al.
Journal of Medicinal Chemistry|February 18, 2014
1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)indoline-4-carbonitrile derivatives as potent and tissue selective androgen receptor modulatorsEugene L Piatnitski Chekler, Rayomond Unwalla, Taukeer A Khan, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nature Chemical Biology|March 20, 2013
Target validation using chemical probesMark E Bunnage, Eugene L Piatnitski Chekler, Lyn H Jones
Journal of the American Chemical Society|November 3, 2010
Electrostatic docking of a supramolecular host-guest assembly to cytochrome c probed by bidirectional photoinduced electron transferKatarzyna I Jankowska, Cynthia V Pagba, Eugene L Piatnitski Chekler, et al.
Scientific Reports|December 17, 2015
Perturbation of cellular proteostasis networks identifies pathways that modulate precursor and intermediate but not mature levels of frataxinJoseph F Nabhan, Renea L Gooch, Eugene L Piatnitski Chekler, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Dual VEGFR-2 and Tubulin Inhibitors with in Vivo EfficacyEugene L Piatnitski Chekler, Alexander S Kiselyov, Xiaohu Ouyang, et al.
Bioorganic & Medicinal Chemistry Letters|July 22, 2008
Synthesis and evaluation of heteroaryl-ketone derivatives as a novel class of VEGFR-2 inhibitorsEugene L Piatnitski Chekler, Reeti Katoch-Rouse, Alexander S Kiselyov, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2009
Discovery of a class of potent gap-junction modifiers as novel antiarrhythmic agentsEugene L Piatnitski Chekler, John A Butera, Li Di, et al.
Journal of Medicinal Chemistry|April 5, 2017
Structure-Based Design of Highly Selective Inhibitors of the CREB Binding Protein BromodomainR Aldrin Denny, Andrew C Flick, Jotham Coe, et al.
Chemistry & Biology|December 17, 2015
Transcriptional Profiling of a Selective CREB Binding Protein Bromodomain Inhibitor Highlights Therapeutic OpportunitiesEugene L Piatnitski Chekler, Jessica A Pellegrino, Thomas A Lanz, et al.
Journal of Medicinal Chemistry|July 12, 2017
Structure-Based Approach To Identify 5-[4-Hydroxyphenyl]pyrrole-2-carbonitrile Derivatives as Potent and Tissue Selective Androgen Receptor ModulatorsRay Unwalla, James J Mousseau, Olugbeminiyi O Fadeyi, et al.
Journal of Medicinal Chemistry|February 18, 2014
1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)indoline-4-carbonitrile derivatives as potent and tissue selective androgen receptor modulatorsEugene L Piatnitski Chekler, Rayomond Unwalla, Taukeer A Khan, et al.
Pageof 2